Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.
2.

Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.

Haas KM, Watanabe R, Matsushita T, Nakashima H, Ishiura N, Okochi H, Fujimoto M, Tedder TF.

J Immunol. 2010 May 1;184(9):4789-800. doi: 10.4049/jimmunol.0902391.

3.

Down-modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis.

Wang C, Li Y, Proctor TM, Vandenbark AA, Offner H.

J Neurosci Res. 2010 Jan;88(1):7-15. doi: 10.1002/jnr.22181.

4.

Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1.

Wang C, Dehghani B, Li Y, Kaler LJ, Vandenbark AA, Offner H.

Immunology. 2009 Mar;126(3):329-35. doi: 10.1111/j.1365-2567.2008.03051.x.

5.

Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1.

Omari KM, Lutz SE, Santambrogio L, Lira SA, Raine CS.

Am J Pathol. 2009 Jan;174(1):164-76. doi: 10.2353/ajpath.2009.080350.

6.

Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.

Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF.

J Clin Invest. 2008 Oct;118(10):3420-30. doi: 10.1172/JCI36030.

7.

Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.

Harp CT, Lovett-Racke AE, Racke MK, Frohman EM, Monson NL.

Clin Immunol. 2008 Sep;128(3):382-91. doi: 10.1016/j.clim.2008.05.002.

PMID:
18599355
8.

A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.

Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF.

Immunity. 2008 May;28(5):639-50. doi: 10.1016/j.immuni.2008.03.017.

9.

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH; HERMES Trial Group..

N Engl J Med. 2008 Feb 14;358(7):676-88. doi: 10.1056/NEJMoa0706383.

10.

Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis.

Duddy M, Niino M, Adatia F, Hebert S, Freedman M, Atkins H, Kim HJ, Bar-Or A.

J Immunol. 2007 May 15;178(10):6092-9.

11.

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, Reynolds R, Aloisi F.

Brain. 2007 Apr;130(Pt 4):1089-104.

PMID:
17438020
12.

Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1).

Polanczyk MJ, Hopke C, Vandenbark AA, Offner H.

Int Immunol. 2007 Mar;19(3):337-43.

13.

PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis.

Carter LL, Leach MW, Azoitei ML, Cui J, Pelker JW, Jussif J, Benoit S, Ireland G, Luxenberg D, Askew GR, Milarski KL, Groves C, Brown T, Carito BA, Percival K, Carreno BM, Collins M, Marusic S.

J Neuroimmunol. 2007 Jan;182(1-2):124-34.

PMID:
17182110
14.

Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.

Bettelli E, Baeten D, Jäger A, Sobel RA, Kuchroo VK.

J Clin Invest. 2006 Sep;116(9):2393-402.

15.

CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis.

Bagaeva LV, Rao P, Powers JM, Segal BM.

J Immunol. 2006 Jun 15;176(12):7676-85.

16.
17.

Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.

Matsushita T, Fujimoto M, Hasegawa M, Komura K, Takehara K, Tedder TF, Sato S.

Am J Pathol. 2006 Mar;168(3):812-21.

18.

Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.

Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisäkk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C, Newcombe J, Hohlfeld R, Meinl E.

Brain. 2006 Jan;129(Pt 1):200-11.

PMID:
16280350
19.

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.

Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C.

Nat Immunol. 2005 Nov;6(11):1133-41.

20.

T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis.

Polanczyk MJ, Jones RE, Subramanian S, Afentoulis M, Rich C, Zakroczymski M, Cooke P, Vandenbark AA, Offner H.

Am J Pathol. 2004 Dec;165(6):2069-77.

Items per page

Supplemental Content

Support Center